Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co. (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co." in English language version.

refsWebsite
Global rank English rank
1st place
1st place
4th place
4th place
4,919th place
2,808th place
2nd place
2nd place
2,275th place
1,288th place
low place
low place
low place
low place
7th place
7th place
low place
low place

doi.org

  • Miller SC, Huang R, Sakamuru S, Shukla SJ, Atten-Rmaos MS, Shinn P, Van leer D, Leister W, Austin CP, Xia M (May 1, 2010). "Identification of known drugs that act as inhibitors of NF-kappaB signaling and their mechanism of action". Biochem. Pharmacol. 79 (9): 1272–80. doi:10.1016/j.bcp.2009.12.021. PMC 2834878. PMID 20067776.
  • "A license to print money?". Nat. Biotechnol. 24 (6): 593. June 2006. doi:10.1038/nbt0606-593. PMID 16763570.

holmansbiotechipblog.blogspot.com

  • Holman, Chris (March 23, 2010). "Pragmatism". Holman's Biotech IP Blog.

iam-magazine.com

leagle.com

  • Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co., 598 F.3d 1336 (Fed. Cir. 2010).
  • Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co., 560 F.3d 1336 (Fed. Cir. 2009).

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Miller SC, Huang R, Sakamuru S, Shukla SJ, Atten-Rmaos MS, Shinn P, Van leer D, Leister W, Austin CP, Xia M (May 1, 2010). "Identification of known drugs that act as inhibitors of NF-kappaB signaling and their mechanism of action". Biochem. Pharmacol. 79 (9): 1272–80. doi:10.1016/j.bcp.2009.12.021. PMC 2834878. PMID 20067776.
  • "A license to print money?". Nat. Biotechnol. 24 (6): 593. June 2006. doi:10.1038/nbt0606-593. PMID 16763570.

ncbi.nlm.nih.gov

  • Miller SC, Huang R, Sakamuru S, Shukla SJ, Atten-Rmaos MS, Shinn P, Van leer D, Leister W, Austin CP, Xia M (May 1, 2010). "Identification of known drugs that act as inhibitors of NF-kappaB signaling and their mechanism of action". Biochem. Pharmacol. 79 (9): 1272–80. doi:10.1016/j.bcp.2009.12.021. PMC 2834878. PMID 20067776.

nytimes.com

patentlyo.com

uscourts.gov

cafc.uscourts.gov

  • Order per curiam, available at, "Archived copy" (PDF). Archived from the original (PDF) on May 27, 2010. Retrieved December 18, 2009.{{cite web}}: CS1 maint: archived copy as title (link)
  • Ariad Pharmaceuticals, Inc., Massachusetts Institute of Technology, The Whitehead Institute for Biomedical Research, and The President and Fellows of Harvard College, V. Eli Lilly and Company, 2008-1248 (United States Court of Appeals for the Federal Circuit 2009-04-03) ("Because we hold that claims 80, 95, 144, and 145 of the ’516 patent are invalid for lack of written description, we need not address infringement or the other validity issues on appeal.").

web.archive.org

wlflegalpulse.com